Loading patent…
AssigneeVical Incorporated
InventorGabriele Hahn
Estimating the term…
A recombinant vector containing infectious genome of human cytomegalovirus (HCMV) and being useful for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion is characterized in that it is obtainable by inserting DNA from a clinical isolate of HCMV virus into a bacterial cloning vehicle. Such vector can be used e.g., for production of reconstituted HCMV virus retaining the phenotypic characteristics of a parental clinical isolate and for studying genes and functions of genes of HCMV virus. A further aspect are mutant viruses and inter alia their use for studying aspects of infectivity of HCMV virus.
A recombinant vector containing the infectious genome of human cytomegalovirus (HCMV) retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells, to induce microfusion and to spread viral material from human umbilical vein endothelial cells (HUVEC) to polymorphonuclear leukocytes (PMNL), obtainable by inserting DNA from a clinical isolate of HCMV virus into a bacterial cloning vehicle wherein the recombinant vector is FIX-Bac-7.
A bacterial cell line containing a recombinant vector containing an infectious genome of human cytomegalovirus (HCMV) retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells, to induce microfusion and to spread viral material from human umbilical vein endothelial cells (HUVEC) to polymorphonuclear leukocytes (PMNL), obtainable by inserting DNA from a clinical isolate of HCMV virus into a bacterial cloning vehicle;
Dependencies are inferred from the claim text.